Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
12.63
-0.01 (-0.08%)
At close: Apr 10, 2026, 4:00 PM EDT
12.75
+0.12 (0.95%)
After-hours: Apr 10, 2026, 5:16 PM EDT
Phathom Pharmaceuticals Market Cap
Phathom Pharmaceuticals has a market cap or net worth of $1 billion as of April 10, 2026. Its market cap has increased by 124.40% in one year.
Market Cap
1.00B
Enterprise Value
1.46B
1-Year Change
124.40%
Ranking
Category
Stock Price
$12.63
Market Cap Chart
Since October 25, 2019, Phathom Pharmaceuticals's market cap has increased from $527.13M to $1.00B, an increase of 90.32%. That is a compound annual growth rate of 10.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 1.00B | -15.00% |
| Dec 31, 2025 | 1.18B | 112.56% |
| Dec 31, 2024 | 555.22M | 6.22% |
| Dec 29, 2023 | 522.72M | 13.23% |
| Dec 30, 2022 | 461.63M | -22.48% |
| Dec 31, 2021 | 595.53M | -36.35% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Geron | 1.07B |
| UroGen Pharma | 1.05B |
| Septerna | 1.04B |
| ORIC Pharmaceuticals | 1.02B |
| Inventiva | 1.01B |
| Xeris Biopharma Holdings | 1.01B |
| KalVista Pharmaceuticals | 993.20M |
| GH Research | 975.10M |